Pharma
NewsBY
- The agency’s 2024-25 departmental results report uses rates from a 2021 survey. Newer data is available, but that source doesn’t include rates from all provinces and territories.
NewsBY
- The agency’s 2024-25 departmental results report uses rates from a 2021 survey. Newer data is available, but that source doesn’t include rates from all provinces and territories.
- MPs have been on the Hill for less than three months this year thanks to prorogation this past winter and the spring election campaign,
- MPs have been on the Hill for less than three months this year thanks to prorogation this past winter and the spring election campaign,
- MPs have been on the Hill for less than three months this year thanks to prorogation this past winter and the spring election campaign,
- Health Minister Marjorie Michel said something could happen with pan-Canadian licensure for doctors in 2026 but the organization responsible for this work isn’t making
- Health Minister Marjorie Michel said something could happen with pan-Canadian licensure for doctors in 2026 but the organization responsible for this work isn’t making
- Health Minister Marjorie Michel said something could happen with pan-Canadian licensure for doctors in 2026 but the organization responsible for this work isn’t making
- Amid the Liberals’ focus on building a stronger economy, Health Minister Marjorie Michel’s office says that faster access to new medicines and supporting researchers
- Amid the Liberals’ focus on building a stronger economy, Health Minister Marjorie Michel’s office says that faster access to new medicines and supporting researchers
- Amid the Liberals’ focus on building a stronger economy, Health Minister Marjorie Michel’s office says that faster access to new medicines and supporting researchers
- A strong government instills confidence in the country’s people and its businesses. This government's waffling on pharmacare does none of that.
- A strong government instills confidence in the country’s people and its businesses. This government's waffling on pharmacare does none of that.
- A strong government instills confidence in the country’s people and its businesses. This government's waffling on pharmacare does none of that.
- A proactive and co-ordinated strategy from the government is essential to safeguard both access and affordability to medicines for the long term.
- A proactive and co-ordinated strategy from the government is essential to safeguard both access and affordability to medicines for the long term.
- A proactive and co-ordinated strategy from the government is essential to safeguard both access and affordability to medicines for the long term.
- Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.
- Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.
- Bill C-64 outlines a proposed first phase towards implementation of national universal pharmacare to address accessibility and affordability of prescription drugs and related products.
- The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.
- The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.
- The proposed new law would likely prohibit Canadians from purchasing supplemental insurance to cover drugs not covered (or only partially covered) by pharmacare.
- The government will likely need to borrow to finance any new spending and add more debt, which will result in higher taxes in the
- The government will likely need to borrow to finance any new spending and add more debt, which will result in higher taxes in the
- The government will likely need to borrow to finance any new spending and add more debt, which will result in higher taxes in the
- Florida’s plan is designed to relieve pressure on an already overburdened government health-care system, and will bring tens, if not hundreds, of millions of
- Florida’s plan is designed to relieve pressure on an already overburdened government health-care system, and will bring tens, if not hundreds, of millions of
- Florida’s plan is designed to relieve pressure on an already overburdened government health-care system, and will bring tens, if not hundreds, of millions of
- The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in
- The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in
- The FDA’s Florida decision might wind up limiting Canadians’ access to pharmaceutical medicines as long as Canadian drug prices remain well below prices in
- Pharmacare and Bill C-234, an act to amend the Greenhouse Gas Pollution Pricing Act, are likely to be top issues for government relations this
- Pharmacare and Bill C-234, an act to amend the Greenhouse Gas Pollution Pricing Act, are likely to be top issues for government relations this
- Pharmacare and Bill C-234, an act to amend the Greenhouse Gas Pollution Pricing Act, are likely to be top issues for government relations this
- A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to
- A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to
- A public pharmacare program that provides coverage for all Canadians, regardless of age, occupation, or income, would alleviate financial burdens and allow people to
- If we want politicians to know what’s important, we need to make sure that they hear answers to questions that get at the heart
- If we want politicians to know what’s important, we need to make sure that they hear answers to questions that get at the heart
- If we want politicians to know what’s important, we need to make sure that they hear answers to questions that get at the heart
- Developers bring new drugs to Canada later than in other nations. Some aren’t launched here at all. The result is that Canadians who need
- Developers bring new drugs to Canada later than in other nations. Some aren’t launched here at all. The result is that Canadians who need
- Developers bring new drugs to Canada later than in other nations. Some aren’t launched here at all. The result is that Canadians who need
- Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.
- Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.
- Private insurers want Canada to embrace a multi-payer pharmacare system without the tools necessary to protect public interests, promote equity, and ensure value.
